Business
Our segments align our products and services with how we manage our business, approach our key markets, and interact with clients through a unified go-to-market approach.
Genpact LTD: Revenue grew 6.6% to $5.08B from $4.767B. Net income grew 7.6% to $552M from $514M. Free cash flow grew 37.9% to $735M from $533M. Operating margin expanded 4 bps to 14.77%. Genpact LTD's annual comparison also shows stock compensation grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 6.6% to $5.08B from $4.767BOK
- Profitability — Net income grew 7.6% to $552M from $514MOK
- Cash flow — Free cash flow grew 37.9% to $735M from $533MOK
- Margins — Operating margin expanded 4 bps to 14.77%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 17 salesWatch
Where the revenue comes from
Fiscal 2025, as Genpact LTD reports it. History and quarterly detail are in the app.
- High Tech and Manufacturing$2.0B
- Consumer and Healthcare$1.7B
- Financial Services$1.4B
Leadership changes
From Genpact LTD's own filings, the day they're filed.
- Anthony Radesca · President · appointmenteff. 2025-09-29
- Genpact Limited · Chief Accounting Officer · departureeff. 2025-09-18
- Donald Klunk · Chief Accounting Officer · departureeff. 2025-09-18
Latest filings
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-05-08
- 8-K · Company announcement2026-05-07
- 8-K · Company announcement2026-04-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Genpact LTD, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.